Browse

Oral Presentation Abstracts

AHNS011

FRAILTY AS A PREDICTOR OF MORBIDITY AND MORTALITY IN MICROVASCULAR RECONSTRUCTIVE HEAD AND NECK PATIENTS

Reconstruction and Rehabilitation

Kelly F Moyer, Shaum S Sridharan

Medstar Georgetown University Hospital


AHNS012

MANDIBULAR RECONSTRUCTION WITH THE TIP OF SCAPULA FREE FLAP

Reconstruction and Rehabilitation

Jeffrey Blumberg, MD1, Paul Walker, MD2, Stephanie Johnson-Obaseki, MD3, Christopher Yao, MD4, Eugene Yu, MD4, Marie-Constance Lacasse, MD4, Stephanie Johnson-Obaseki, MD3, David Lam, MD, DDS, PHD4, Brian Rittenberg, DDS5, Douglas Chepeha, MD4, John de Almeida, MD4, David Goldstein, MD4, Ralph Gilbert, MD4

1University of North Carolina at Chapel Hill, 2Loma Linda University, 3University of Ottawa, 4University of Toronto, 5Mount Sinai Hospital, Toronto, ON


AHNS013

ADJUVANT RADIATION FOR POSITIVE MARGINS IN ADULT H&N SARCOMAS IS ASSOCIATED WITH IMPROVED SURVIVAL: ANALYSIS OF THE NATIONAL CANCER DATABASE

Immunotherapy and Other Adjuvant Treatments

Amanda J Kull, MD, Sam Francis, MD, Luke O Buchmann, MD, Jason P Hunt, MD, Shane Lloyd, MD, Ying J Hitchcock, MD, John R Weis, MD, Marcus M Monroe, MD

University of Utah


AHNS014

PD-L1 MAY SERVE AS A PROGNOSTIC BIOMARKER IN HPV-ASSOCIATED HEAD AND NECK CANCER PATIENTS

Immunotherapy and Other Adjuvant Treatments

Austin K Mattox1, Francesco Sabbatino2, Vincenzo Villani2, Soldano Ferrone2, William C Faquin3, Hang Lee4, Jill Brooks5, Armida Lefranc-Torres6, Derrick T Lin6, Lori J Wirth7, Christopher C McConkey8, Hisham Mehanna5, Sara I Pai2

1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Institute of Head and Neck Studies and Education (InHANSE), University of Birmingham, UK, 6Department of Otology and Laryngology, Massachusetts Eye and Ear Infirmary, Boston, MA, 7Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 8Warwick Clinical Trials Unit, University of Warwick, UK


AHNS015

THE ADDITION OF CHEMOTHERAPY TO THE ADJUVANT THERAPY OF LATE-STAGE SALIVARY SQUAMOUS CELL CARCINOMA IS ASSOCIATED WITH IMPROVED PATIENT SURVIVAL

Immunotherapy and Other Adjuvant Treatments

Shayan Cheraghlou, BA, Cheryl K Zogg, MSPH, MHS, Michael D Otremba, MD, Henry S Park, MD, MPH, Aarti Bhatia, MD, MPH, Saral Mehra, MD, MBA, Heather A Osborn, MD, Wendell G Yarbrough, MD, Benjamin L Judson, MD

Yale Medical School


AHNS016

ADJUVANT RADIATION FOR T1-2N1M0 ORAL CAVITY CANCER IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES: ANALYSIS OF THE SEER DATABASE

Oral Cancer

Hailey M Shepherd, BS, Vanessa Torrecillas, MD, Patrick Carpenter, MD, Sam Francis, MD, Luke O Buchmann, MD, Marcus M Monroe, MD, Shane Lloyd, MD, Donald Cannon, MD, Ying J Hitchcock, MD, John R Weis, MD, Jason P Hunt, MD

University of Utah


AHNS017

DOES PERIOPERATIVE OXANDROLONE IMPROVE NUTRITIONAL STATUS IN PATIENTS WITH CACHEXIA RELATED TO HEAD AND NECK CARCINOMA?

Immunotherapy and Other Adjuvant Treatments

Angela M Osmolak, MD, Cristine Klatt-Lasso, MD, Amber Price, MD, Jose A Sanclement, MD, Greg A Krempl, MD

University of Oklahoma Health Science Center


AHNS018

LONGITUDINAL IMMUNE COMPLEXITY ANALYSIS USING 29-BIOMARKER MULTIPLEX IMMUNOHISTOCHEMISTRY IN PRIMARY AND RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA

Immunotherapy and Other Adjuvant Treatments

Grace L Banik, MD1, Rie Kawashima, DDS, PhD2, Tiziana Cotechini, PhD2, Sara I Pai, MD, PhD3, Armida LeFranc-Torres4, Derrick T Lin, MD4, Lori J Wirth, MD5, Daniel R Clayburgh, MD, PhD6, Lisa M Coussens, PhD7, Takahiro Tsujikawa, MD, PhD8

1Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, 2Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, 3Department of Surgery, Massachusetts General Hospital, Harvard University, 4Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 5Department of Medicine, Massachusetts General Hospital, Harvard University, 6Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University; Knight Cancer Institute, Oregon Health and Science University, 7Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University; Knight Cancer Institute, Oregon Health and Science University, 8Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University; Knight Cancer Institute, Oregon Health and Science University; Department of Otolaryngology, Head and Neck Surgery, Kyoto Prefectural University of Medicine


AHNS019

VOICE OUTCOMES FOLLOWING SURGERY FOR THYROID CANCER

Thyroid Cancer

Kevin J Kovatch, MD1, David Reyes-Gastelum, PhD2, David T Hughes, MD3, Ann S Hamilton, PhD4, Kevin Ward, PhD, MPH5, Megan R Haymart, MD2

1University of Michigan, Department of Otolaryngology-Head and Neck Surgery, 2University of Michigan, Department of Metabolism, Endocrinology, and Diabetes, 3University of Michigan, Department of General Surgery, 4Keck School of Medicine, University of Southern California, Department of Preventive Medicine, 5Emory University, Department of Epidemioloy


AHNS020

UTILITY OF INTRAOPERATIVE FROZEN SECTION IN LARGE THYROID NODULES

Thyroid Cancer

Craig A Bollig, MD, Jeffrey B Jorgensen, MD, Robert P Zitsch, III, MD, Laura M Dooley, MD

University of Missouri Dept. of Otolaryngology Head and Neck Surgery